[go: up one dir, main page]

Aguirre-Zapata et al., 2016 - Google Patents

Monitoreo de la Concentracion de la Glucosa Plasmatica en Pacientes en Cuidados Intensivos usando Mediciones de Glucosa Intersticial.

Aguirre-Zapata et al., 2016

Document ID
12150571792583507558
Author
Aguirre-Zapata E
García-Tirado J
Publication year
Publication venue
Ingenierías USBmed

External Links

Snippet

La homeostasis de la glucosa es responsable de mantener la concentración de glucosa en sangre alrededor de 100 mg/dl. Cuando este mecanismo está roto por la incapacidad del páncreas para producir insulina, los niveles de glucosa en la sangre aumentan y los …
Continue reading at go.gale.com (other versions)

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3437—Medical simulation or modelling, e.g. simulating the evolution of medical disorders
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3406—Local monitoring or local control of medical devices, e.g. configuration parameters, graphical user interfaces [GUI] or dedicated hardware interfaces
    • G06F19/3412—Medical equipment management, e.g. updates or maintenance
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3418—Telemedicine, e.g. remote diagnosis, remote control of instruments or remote monitoring of patient carried devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters; Monitoring media flow to the body electrical or electronic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F11/00—Error detection; Error correction; Monitoring

Similar Documents

Publication Publication Date Title
US20260007370A1 (en) Method, system and computer readable medium for assessing actionable glycemic risk
Pappada et al. Development of a neural network for prediction of glucose concentration in type 1 diabetes patients
Wernerman et al. Continuous glucose control in the ICU: report of a 2013 round table meeting
Service Glucose variability
Vettoretti et al. Type-1 diabetes patient decision simulator for in silico testing safety and effectiveness of insulin treatments
Hovorka Continuous glucose monitoring and closed‐loop systems
Preiser et al. Near-continuous glucose monitoring makes glycemic control safer in ICU patients
Staal et al. Kalman smoothing for objective and automatic preprocessing of glucose data
Eberle et al. Real-time state estimation and long-term model adaptation: a two-sided approach toward personalized diagnosis of glucose and insulin levels
Wilinska et al. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies
Kovatchev et al. Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology
Price et al. The rationale for continuous glucose monitoring-based diabetes treatment decisions and non-adjunctive continuous glucose monitoring use
Zhou et al. Proportion of time spent in blood glucose range 70 to 140 mg/dL is associated with increased survival in patients admitted to ICU after cardiac arrest: A multicenter observational study
Georga et al. Personalized predictive modeling in type 1 diabetes
Koutny et al. Parallel software architecture for the next generation of glucose monitoring
Breton et al. Analysis of the accuracy and performance of a continuous glucose monitoring sensor prototype: an in-silico study using the UVA/PADOVA type 1 diabetes simulator
Daud et al. Meal simulation in glucose-insulin reaction analysis using Hovorka model towards system-on-chip implementation
Annuzzi et al. Predicting and monitoring blood glucose through nutritional factors in type 1 diabetes by artificial neural networks
Kovatchev Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes
Gottschalk et al. Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy
Koutny Modelling of glucose dynamics for diabetes
Aguirre-Zapata et al. Monitoreo de la Concentracion de la Glucosa Plasmatica en Pacientes en Cuidados Intensivos usando Mediciones de Glucosa Intersticial.
Cescon et al. Glycemic trend prediction using empirical model identification
Holder-Pearson et al. Model-based modified OGTT insulin sensitivity test design
Lee et al. Postprandial capillary–venous glucose gradient in Type 1 diabetes: magnitude and clinical associations in a real world setting